REGN
Regeneron Pharmaceuticals Inc
Price:  
778.50 
USD
Volume:  
1,249,739.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron Probability of Bankruptcy

The Probability of Bankruptcy of Regeneron Pharmaceuticals Inc (REGN) is 1.20% . This number represents the probability that Regeneron will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating Regeneron's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

Regeneron - ESG ratings

ESG ratings are directly linked to the cost of capital and Regeneron's ability to raise funding, both of which can significantly affect the probability of Regeneron Pharmaceuticals Inc going bankrupt.

ESG Score 63.79
Environment Score 68.63
Social Score 99.00
Governance Score 23.75
Returns
Historical Returns (5 day) 3.21%
Historical Returns (MTD) 3.77%
Historical Returns (YTD) -11.36%
Historical Returns (13 week) -31.49%
Historical Returns (26 week) -22.21%
Historical Returns (52 week) -8.24%
Efficiency
Asset Turnover 0.39
Receiveable Turnover 2.37
Gross Margin 86.86%
Operating Margin 28.69%
Pretax Margin 35.89%
Net Margin 33.61%
Return on Asset (ROA) 13.21
Return on Equity (ROE) 16.85
Return on Investments (ROI) 15.35
Price Metrics
Market Cap (M) 85,549.37
Enterprise Value (M)
52 Week High 1,211.20
52 Week Low 735.95
Beta 0.78
Average Volume (10 day) 0.80
Average Volume (3 month) 0.69
Price / Earnings (P/E) 18.60
Price / Sales (P/S) 6.25
Earnings
EPS 40.42
Revenue CAGR (5 year) 14.34%
Risk
Current Ratio 5.28
Quick Ratio 4.34